Recursion Pharmaceuticals, Inc. (RXRX)
UT
Total Compensation for Fiscal Year Ending in 2023: $8,613,209
| Salary | $560,833 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $3,478,140 |
| Value of Option Awards | $4,328,352 |
| Non-Equity Incentive Plan Compensation | $224,483 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $21,400 |
| Total | $8,613,209 |
Recursion Pharmaceuticals, Inc. disclosed its CEO pay was
35
times its median employee's pay for the fiscal year ending in 2023.
How Do You Compare?
